Allan D Herrmann

Array ( [id] => 2832429 [patent_doc_number] => 05175269 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-29 [patent_title] => 'Compound and detectable molecules having an oligo- or polynucleotide with modifiable reactive group' [patent_app_type] => 1 [patent_app_number] => 7/692865 [patent_app_country] => US [patent_app_date] => 1991-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14635 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 235 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/175/05175269.pdf [firstpage_image] =>[orig_patent_app_number] => 692865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2969575 [patent_doc_number] => 05202423 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-13 [patent_title] => 'Terpyridine derivatives' [patent_app_type] => 1 [patent_app_number] => 7/687498 [patent_app_country] => US [patent_app_date] => 1991-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8346 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/202/05202423.pdf [firstpage_image] =>[orig_patent_app_number] => 687498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2781727 [patent_doc_number] => 05130130 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-14 [patent_title] => 'Phospholipase A2 conjugated to a tarqeting moiety and their therapeutic compositions' [patent_app_type] => 1 [patent_app_number] => 7/679927 [patent_app_country] => US [patent_app_date] => 1991-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 4252 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/130/05130130.pdf [firstpage_image] =>[orig_patent_app_number] => 679927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2778677 [patent_doc_number] => 05141648 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-08-25 [patent_title] => 'Methods for isolating compounds using cleavable linker bound matrices' [patent_app_type] => 1 [patent_app_number] => 7/678535 [patent_app_country] => US [patent_app_date] => 1991-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14021 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/141/05141648.pdf [firstpage_image] =>[orig_patent_app_number] => 678535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3049575 [patent_doc_number] => 05344645 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-06 [patent_title] => 'Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived therefrom' [patent_app_type] => 1 [patent_app_number] => 7/673671 [patent_app_country] => US [patent_app_date] => 1991-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7071 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/344/05344645.pdf [firstpage_image] =>[orig_patent_app_number] => 673671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2796154 [patent_doc_number] => 05144012 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-01 [patent_title] => 'Cytotoxic drug conjugates' [patent_app_type] => 1 [patent_app_number] => 7/656343 [patent_app_country] => US [patent_app_date] => 1991-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9424 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/144/05144012.pdf [firstpage_image] =>[orig_patent_app_number] => 656343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2785373 [patent_doc_number] => 05164488 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-17 [patent_title] => 'New hemiacetal compounds and the applications thereof' [patent_app_type] => 1 [patent_app_number] => 7/654517 [patent_app_country] => US [patent_app_date] => 1991-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6291 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 277 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/164/05164488.pdf [firstpage_image] =>[orig_patent_app_number] => 654517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2820406 [patent_doc_number] => 05167956 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-01 [patent_title] => 'Immunotoxin with in-vivo T cell suppressant activity' [patent_app_type] => 1 [patent_app_number] => 7/653164 [patent_app_country] => US [patent_app_date] => 1991-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4060 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/167/05167956.pdf [firstpage_image] =>[orig_patent_app_number] => 653164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2665534 [patent_doc_number] => 05047227 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-09-10 [patent_title] => 'Novel and improved antibodies for site specific attachment of compounds' [patent_app_type] => 1 [patent_app_number] => 7/650363 [patent_app_country] => US [patent_app_date] => 1991-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6286 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/047/05047227.pdf [firstpage_image] =>[orig_patent_app_number] => 650363 [rel_patent_id] =>[rel_patent_doc_number] =>)